Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Diluted earnings per share
Latest
-0.27
↓ 110% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-0.13
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -0.27 | -195.5% |
| 2024 | -0.09 | +22.5% |
| 2023 | -0.12 | +20.0% |
| 2022 | -0.15 | +42.3% |
| 2021 | -0.26 | -85.7% |
| 2020 | -0.14 | -72.2% |
| 2019 | -0.08 | +77.4% |
| 2018 | -0.36 | -111.8% |
| 2017 | -0.17 | -150.0% |
| 2016 | 0.34 | - |